(Q38116807)

29 August 2017

title

Depression in Parkinson's disease: identification and management (English)

1 reference

29 August 2017

1 reference

Jack J Chen

1

1 reference

29 August 2017

Laura Marsh

series ordinal

2

1 reference

29 August 2017

language of work or name

English

0 references

publication date

24 June 2013

1 reference

29 August 2017

1 reference

29 August 2017

volume

33

1 reference

29 August 2017

issue

9

1 reference

29 August 2017

page(s)

972-983

1 reference

Factors impacting on quality of life in Parkinson's disease: results from an international survey.

29 August 2017

cites work

1 reference

Mortality in Parkinson's disease and its association with dementia and depression.

21 January 2018

1 reference

Provisional diagnostic criteria for depression in Parkinson's disease: report of an NINDS/NIMH Work Group

21 January 2018

1 reference

Non-recognition of depression and other non-motor symptoms in Parkinson's disease

21 January 2018

1 reference

Depression in Parkinson's disease: clinical correlates and outcome

21 January 2018

1 reference

Depressive symptoms in Parkinson's disease: a comparison with disabled control subjects

21 January 2018

1 reference

Higher incidence of depression preceding the onset of Parkinson's disease: a register study

21 January 2018

1 reference

Deep brain stimulation for Parkinson disease: an expert consensus and review of key issues

21 January 2018

1 reference

Serotonin-dependent depression in Parkinson's disease: a role for the subthalamic nucleus?

21 January 2018

1 reference

Imaging correlates of apathy and depression in Parkinson's disease

21 January 2018

1 reference

Development of quality of care indicators for Parkinson's disease

21 January 2018

1 reference

Collaborative care for depression: a cumulative meta-analysis and review of longer-term outcomes

21 January 2018

1 reference

Specificity of affective and autonomic symptoms of depression in Parkinson's disease

21 January 2018

1 reference

Screening for depression in adults: a summary of the evidence for the U.S. Preventive Services Task Force

21 January 2018

1 reference

A comparison of nine scales to detect depression in Parkinson disease: which scale to use?

21 January 2018

1 reference

Test characteristics of the 15-item geriatric depression scale and Hamilton depression rating scale in Parkinson disease

21 January 2018

1 reference

SSRIs do not worsen Parkinson's disease: evidence from an open-label, prospective study.

21 January 2018

1 reference

Response to 4-month treatment with reboxetine in Parkinson's disease patients with a major depressive episode

21 January 2018

1 reference

Remarkable effect of milnacipran, a serotonin-noradrenalin reuptake inhibitor (SNRI), on depressive symptoms in patients with Parkinson's disease who have insufficient response to selective serotonin reuptake inhibitors (SSRIs): two case reports

21 January 2018

1 reference

The SSRI, citalopram, improves bradykinesia in patients with Parkinson's disease treated with L-dopa

21 January 2018

1 reference

Sertraline for the treatment of depression in Parkinson's disease.

21 January 2018

1 reference

Randomized study of sertraline and low-dose amitriptyline in patients with Parkinson's disease and depression: effect on quality of life.

21 January 2018

1 reference

Repetitive transcranial magnetic stimulation is as effective as fluoxetine in the treatment of depression in patients with Parkinson's disease.

21 January 2018

1 reference

Does Nefazodone Improve Both Depression and Parkinson Disease? A Pilot Randomized Trial

21 January 2018

1 reference

SSRIs in the treatment of depression in Parkinson's disease

21 January 2018

1 reference

Comparison of desipramine and citalopram treatments for depression in Parkinson's disease: a double-blind, randomized, placebo-controlled study

21 January 2018

1 reference

A controlled trial of antidepressants in patients with Parkinson disease and depression

21 January 2018

1 reference

A randomized, double-blind, placebo-controlled trial of antidepressants in Parkinson disease.

21 January 2018

1 reference

Sertraline in the treatment of depressive disorders in patients with Parkinson's disease

21 January 2018

1 reference

Moclobemide and selegeline in the treatment of depression in Parkinson's disease

21 January 2018

1 reference

A non-comparative assessment of tolerability and efficacy of duloxetine in the treatment of depressed patients with Parkinson's disease

21 January 2018

1 reference

Efficacy and acceptability of selective serotonin reuptake inhibitors for the treatment of depression in Parkinson's disease: a systematic review and meta-analysis of randomized controlled trials

21 January 2018

1 reference

The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the non-motor symptoms of Parkinson's disease

21 January 2018

1 reference

Valproic acid-induced parkinsonism in the elderly: a comprehensive review of the literature

21 January 2018

1 reference

Mirtazapine treats resting tremor, essential tremor, and levodopa-induced dyskinesias

21 January 2018

1 reference

Atomoxetine for depression and other neuropsychiatric symptoms in Parkinson disease

21 January 2018

1 reference

Pramipexole and pergolide in the treatment of depression in Parkinson's disease: a national multicentre prospective randomized study.

21 January 2018

1 reference

Pramipexole for the treatment of depressive symptoms in patients with Parkinson's disease: a randomised, double-blind, placebo-controlled trial

21 January 2018

1 reference

Effects of ropinirole on nonmotor symptoms of Parkinson disease: a prospective multicenter study

21 January 2018

1 reference

Impulse control disorders in Parkinson disease: a cross-sectional study of 3090 patients

21 January 2018

1 reference

Cognitive-behavioral therapy for depression in Parkinson's disease: a randomized, controlled trial

21 January 2018

1 reference

The impact of left prefrontal repetitive transcranial magnetic stimulation on depression in Parkinson's disease: a randomized, double-blind, placebo-controlled study.

21 January 2018

1 reference

Comparison of the effects of a physiotherapist-supervised exercise programme and a self-supervised exercise programme on quality of life in patients with Parkinson's disease

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/PHAR.1314

1 reference

29 August 2017

1 reference